Patient engagement: How one pharmaceutical company is failing to adapt.
There is an increasing desire in the research community (public and private) to include patients throughout the medicines development process. This involves a big change is the way these organisations interact with us. It is a challenge, as working with the public and patients often requires a different way of preparing for and organising of …
Patient engagement: How one pharmaceutical company is failing to adapt. Read More »